Skip to main content
OpenTrials
Completed

NCT Number: NCT01031615

Evaluation of the Child and Family Traumatic Stress Intervention

The purpose of this study is to determine the efficacy of the Child and Family Traumatic Stress Intervention (CFTSI) in preventing the development of Posttraumatic Stress Disorder (PTSD) when implemented within 30 days of a potentially traumatic event.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Posttraumatic Stress Disorder Mental Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

7 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Yale University Child Study Center

New Haven, Connecticut, 06520, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Youth exposed to a potentially traumatic event within the last 30 days who have one new symptom on the Posttraumatic Checklist (PCL)

Exclusion criteria

  • Already receiving mental health treatment
  • Autism or Developmental Disability
  • Diagnosed with psychosis or bipolar disorder
  • Non-english speaking

Treatment and study plan

Child and Family Traumatic Stress Interv (CFTSI)

Behavioral

4 sessions involving both the target child and a parent/caregiver

Psychoeducational Comparison

Behavioral

4 individually focused sessions including psychoeducation and relaxation.

Primary outcomes

  1. UCLA Posttraumatic Reaction Index (PTSD-RI)

    Time frame: 3 months post-intervention

Secondary outcomes

  1. Trauma Symptom Checklist for Children (TSCC)

    Time frame: 3 Months post-intervention

Sponsors and collaborators

Lead sponsor

Yale University

Other

Registry information

Acronym: CFTSI

Important dates

Study start
2005
Primary completion
2009
Study completion
2009
First posted
Dec 14, 2009
Registry last updated
Jun 16, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.